Russia - Revision history

Natalie Oveyssi at 21:14, 29 July 2015

2015-07-29T21:14:13Z

Natalie Oveyssi at 21:11, 29 July 2015

2015-07-29T21:11:33Z

Natalie Oveyssi at 21:10, 29 July 2015

2015-07-29T21:10:57Z

Natalie Oveyssi at 21:57, 27 July 2015

2015-07-27T21:57:46Z

Natalie Oveyssi at 20:13, 15 July 2015

2015-07-15T20:13:07Z

Sonia Allan at 12:43, 22 February 2015

2015-02-22T12:43:34Z

Peteshan at 20:50, 3 March 2010

2010-03-03T20:50:20Z

New page

{{Country
|name=Russian Federation
|image_flag=Russia_flag.gif
|Region=Europe
|Population=142,008,838
|GDP=1,289,582
|Eggs for assisted reproduction=commercial allowed
|Eggs for research=commercial allowed
|Inheritable genetic modification=?
|Preimplantation genetic diagnosis=social uses prohibited
|Reproductive cloning=PROHIBITED
|Research cloning=PROHIBITED
|Sex selection=social uses prohibited
|Surrogacy=commercial allowed
|Council of Europe=Member
|2005 UN Cloning Vote=no vote
|2005 UNESCO Sports Doping Convention=RATIFIED
|Treaty of Lisbon=n/a
|Key laws and policies=* On transplantation of human organs (tissues)* (22.12.1992 № 4179-1,)
* Family Code (1995)
* On temporary prohibition of human cloning (№ 54 FZ, 2002)
|Prohibited practices=Reproductive cloning is prohibited under a five-year moratorium, renewed in 2010."[http://en.rian.ru/russia/20091002/156329425.html Russia extends human cloning ban]," RiaNovosti (October 2, 2009)
Research cloning is prohibited.Human Fertility and Embryology Authority (UK), "[http://www.hfea.gov.uk/en/1579.html Hybrids and Chimeras: Findings of the Consultation, Annex C – International Perspective]," September 5, 2007
|Permitted and regulated practices=Surrogacy, including payments, is explicitly permitted by the 1995 Family Code.Konstantin Svitnev, "[http://www.eshre.com/emc.asp?pageId=835 Russian Legislation]", European Society for Human Reproduction and Embryology (accessed on June 1, 2008)

Payments for gametes is allowed by the Law On transplantation of human organs.Konstantin Svitnev, "[http://www.eshre.com/emc.asp?pageId=835 Russian Legislation]", European Society for Human Reproduction and Embryology (accessed on June 1, 2008)

PGDs and sex selection are allowed only when there is a risk of giving birth to children with hereditary pathologies.
|History=A five-year moratorium on human reproductive cloning expired in 2007 and was not renewed until 2010.

The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines and the use of embryos.Petja Papula, "[http://www.iprinfo.com/page.php?page_id=35&action=articleDetails&a_id=543&id=37 Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), accessed on July 8, 2008.
}}
== References ==

@@ Line 37: / Line 37: @@
 '''Research Cloning'''
-* Research cloning is prohibited.Human Fertility and Embryology Authority (UK), "[http://www.hfea.gov.uk/en/1579.html Hybrids and Chimeras: Findings of the Consultation, Annex C – International Perspective]," September 5, 2007.
+* Research cloning is prohibited.Human Fertility and Embryology Authority (UK), "[http://www.hfea.gov.uk/docs/Hybrids_Report.pdf Hybrids and Chimeras: Findings of the Consultation, Annex C – International Perspective]," September 5, 2007.
 |Permitted and regulated practices=Article 55 of Federal law No. 323-FZ of 21.11.2011, "On the Fundamentals of Citizens’ Health Protection in the Russian Federation," gives the definition of assisted reproductive technologies and determines the group of persons entitled to use such technologies, as well as those who are entitled to be germ cell donors.
@@ Line 78: / Line 78: @@
 |History=A five-year moratorium on human reproductive cloning expired in 2007 and was not renewed until 2010.
-The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines, and the use of embryos.Petja Papula, "[http://www.iprinfo.com/page.php?page_id=35&action=articleDetails&a_id=543&id=37 Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), (accessed on July 8, 2008).
+The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines, and the use of embryos.Petja Papula, "[http://www.iprinfo.com/julkaisut/iprinfo-lehti/lehtiarkisto/2008/IPRinfo_1-2008/fi_FI/Russian_IP_Reform_Brings_Changes_in_Patenting__Design_Remains_a_Strong_Form_of_Protection/ Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), (accessed on July 8, 2008).
 |External links=
 }}
 == References ==

← Older revision		Revision as of 21:11, 29 July 2015
Line 41:		Line 41:


−	According to a [http://www.hcch.net/upload/wop/gap2014pd3ru.pdf questionnaire] from the Hague Conference on Private International Law, Russian law indicates the following:	+	According to an April 2013 [http://www.hcch.net/upload/wop/gap2014pd3ru.pdf questionnaire] from the Hague Conference on Private International Law, Russian law indicates the following:

	"1. Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).		"1. Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).

@@ Line 40: / Line 40: @@
 |Permitted and regulated practices=Article 55 of Federal law No. 323-FZ of 21.11.2011, "On the Fundamentals of Citizens’ Health Protection in the Russian Federation," gives the definition of assisted reproductive technologies and determines the group of persons entitled to use such technologies, as well as those who are entitled to be germ cell donors.
-Federal law No. 323-FZ of 21.11.2011, "On the Fundamentals of Citizens’ Health Protection in the Russian Federation," Article 55. Application of assisted reproductive technologies:
 "1. Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).

@@ Line 42: / Line 42: @@
 Federal law No. 323-FZ of 21.11.2011, "On the Fundamentals of Citizens’ Health Protection in the Russian Federation," Article 55. Application of assisted reproductive technologies:
-. Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).
+"1. Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).
 . The procedure for the use of assisted reproductive technologies, contraindications and restrictions to their application shall be approved by the authorized federal executive authority.
@@ Line 57: / Line 57: @@
 . Upon the use of donor germ cells and embryos the citizens are entitled to obtain
-information on the results of medical, medical and genetic examination of the donor, on his race and ethnicity, and on his appearance.
+information on the results of medical, medical and genetic examination of the donor, on his race and ethnicity, and on his appearance."

@@ Line 22: / Line 22: @@
 |Treaty of Lisbon=n/a
 |Introduction=
-|Key laws and policies=* On transplantation of human organs (tissues)* (22.12.1992 № 4179-1,)
+|Key laws and policies=* On transplantation of human organs (tissues)* (22.12.1992 № 4179-1)
 * Family Code (1995)
 * On temporary prohibition of human cloning (№ 54 FZ, 2002)
-The use of ART is regulated by order No. 107н of the Ministry of Healthcare of Russia dated 30 August 2012 “On the Procedure for the Use of Assisted Reproductive Technologies, Contraindications and Restrictions to their Application”. (See http://www.garant.ru/products/ipo/prime/doc/70218364/)
+The use of ART is regulated by order No. 107н of the Ministry of Healthcare of Russia dated 30 August 2012, “On the Procedure for the Use of Assisted Reproductive Technologies, Contraindications and Restrictions to their Application.” (See http://www.garant.ru/products/ipo/prime/doc/70218364/.)
-Federal law No. 323-FZ of 21.11.2011 "On the Fundamentals of Citizens’ Health Protection in the Russian Federation" (Defines assisted reproduction)
+Federal law No. 323-FZ of 21.11.2011, "On the Fundamentals of Citizens’ Health Protection in the Russian Federation," defines assisted reproduction.
 |Foundational values=
-|Prohibited practices=REPRODUCTIVE CLONING
+|Prohibited practices='''Reproductive Cloning'''
-* Reproductive cloning is prohibited under a five-year moratorium, renewed in 2010."[http://en.rian.ru/russia/20091002/156329425.html Russia extends human cloning ban]," RiaNovosti (October 2, 2009)
+* Reproductive cloning is prohibited under a five-year moratorium, renewed in 2010."[http://en.rian.ru/russia/20091002/156329425.html Russia extends human cloning ban]," RiaNovosti, (October 2, 2009).
-* Research cloning is prohibited.Human Fertility and Embryology Authority (UK), "[http://www.hfea.gov.uk/en/1579.html Hybrids and Chimeras: Findings of the Consultation, Annex C – International Perspective]," September 5, 2007
+'''Research Cloning'''
-|Permitted and regulated practices=Article 55 of Federal law No. 323-FZ of 21.11.2011 "On the Fundamentals of Citizens’ Health Protection in the Russian Federation" gives the definition of assisted reproductive technologies, determines the group of persons entitled to use such technologies, and those who are entitled to be germ cell donors.
-Federal law No. 323-FZ of 21.11.2011 "On the Fundamentals of Citizens’ Health Protection in the Russian Federation". Article 55. Application of assisted reproductive technologies
+* Research cloning is prohibited.Human Fertility and Embryology Authority (UK), "[http://www.hfea.gov.uk/en/1579.html Hybrids and Chimeras: Findings of the Consultation, Annex C – International Perspective]," September 5, 2007.
 . Assisted reproductive technologies present infertility treatment methods, upon application whereof some or all stages of conception and early development of embryo occur outside mother’s organism (including with the use of donor and (or) cryopreserved germ cells, tissues of genital organs or embryos, as well as surrogacy).
@@ Line 53: / Line 54: @@
 . Germ cells, tissues of genital organs or human embryos cannot be used for industrial purposes.
-. The citizens aged from eighteen to thirty five, physically and mentally healthy, who have passed medical and genetic examination, may be donors of germ cells.
+. The citizens aged from eighteen to thirty-five, physically and mentally healthy, who have passed medical and genetic examination, may be donors of germ cells.
 . Upon the use of donor germ cells and embryos the citizens are entitled to obtain
 information on the results of medical, medical and genetic examination of the donor, on his race and ethnicity, and on his appearance.
-SURROGACY
 . Surrogacy means bearing and delivery of a child (including premature delivery) under a contract to be signed between the surrogate mother (the woman bearing the fetus after transfer of donor embryo) and the prospective parents, whose germ cells have been used for fertilization, or the single woman, who is unable to carry and deliver a child due to medical reasons.
@@ Line 65: / Line 67: @@
 Indications for the use of surrogacy are as follows:
-* ametria (congenital or acquired);
+* Ametria (congenital or acquired)
-* deformity of uterine cavity or cervix due to congenital malformation or in the result of diseases;
+* Deformity of uterine cavity or cervix due to congenital malformation or in the result of diseases
-* endometrium pathology (synechia, obliteration of uterine cavity, endometrium atrophy);
+* Endometrium pathology (synechia, obliteration of uterine cavity, endometrium atrophy)
-* diseases (conditions) included into the List of contraindications (appendix No. 2 to order No. 107н of the Ministry of Healthcare of Russia dated 30.08.2012);
+* Diseases (conditions) included into the List of contraindications (appendix No. 2 to order No. 107н of the Ministry of Healthcare of Russia dated 30.08.2012)
-* failed repeated IVF attempts (3 and more) in the event of multiple receipt of good quality embryos, the transfer whereof fails to result in pregnancy;
+* Failed repeated IVF attempts (3 and more) in the event of multiple receipt of good quality embryos, the transfer whereof fails to result in pregnancy
-* refractory pregnancy loss (3 and more spontaneous miscarriages in the medical history).
+* Refractory pregnancy loss (3 and more spontaneous miscarriages in the medical history)
-−
 |Regulatory activities=
 |Accountability and governance=
 |History=A five-year moratorium on human reproductive cloning expired in 2007 and was not renewed until 2010.
-The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines and the use of embryos.Petja Papula, "[http://www.iprinfo.com/page.php?page_id=35&action=articleDetails&a_id=543&id=37 Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), accessed on July 8, 2008.
+The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines, and the use of embryos.Petja Papula, "[http://www.iprinfo.com/page.php?page_id=35&action=articleDetails&a_id=543&id=37 Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), (accessed on July 8, 2008).
 |External links=
 }}
 == References ==

@@ Line 3: / Line 3: @@
 |image_flag=Russia_flag.gif
 |Region=Europe
-|Population=142,008,838
+|Population=142008838
-|GDP=1,289,582
+|GDP=1289582
 |Eggs for assisted reproduction=commercial allowed
 |Eggs for research=commercial allowed
@@ Line 11: / Line 11: @@
 |Reproductive cloning=PROHIBITED
 |Research cloning=PROHIBITED
-|Sex selection=social uses prohibited
+|Sex selection=Social uses prohibited
 |Surrogacy=commercial allowed
 |Council of Europe=Member
 |2005 UN Cloning Vote=no vote
 |2005 UNESCO Sports Doping Convention=RATIFIED
 |Treaty of Lisbon=n/a
 |Key laws and policies=* On transplantation of human organs (tissues)* (22.12.1992 № 4179-1,)
 * Family Code (1995)
 * On temporary prohibition of human cloning (№ 54 FZ, 2002)
-Payments for gametes is allowed by the Law On transplantation of human organs.Konstantin Svitnev, "[http://www.eshre.com/emc.asp?pageId=835 Russian Legislation]", European Society for Human Reproduction and Embryology (accessed on June 1, 2008)</ref>
+The use of ART is regulated by order No. 107н of the Ministry of Healthcare of Russia dated 30 August 2012 “On the Procedure for the Use of Assisted Reproductive Technologies, Contraindications and Restrictions to their Application”. (See http://www.garant.ru/products/ipo/prime/doc/70218364/)
-PGDs and sex selection are allowed only when there is a risk of giving birth to children with hereditary pathologies.eshre/>
+Federal law No. 323-FZ of 21.11.2011 "On the Fundamentals of Citizens’ Health Protection in the Russian Federation" (Defines assisted reproduction)
 |History=A five-year moratorium on human reproductive cloning expired in 2007 and was not renewed until 2010.
 The 2008 Patent Act for the first time explicitly prohibits patents involving human cloning, modifications of human cell lines and the use of embryos.Petja Papula, "[http://www.iprinfo.com/page.php?page_id=35&action=articleDetails&a_id=543&id=37 Russian IP Reform Brings Changes in Patenting]," IPRInfo (January, 2008), accessed on July 8, 2008.
 }}
 == References ==